Business Description
Akums Drugs and Pharmaceuticals Ltd
ISIN : INE09XN01023
Total Employee Number:
17,864Compare
Compare
Traded in other countries / regions
544222.India Index Membership
NIFTY 500 IPO Date
2024-08-06Description
Akums Drugs and Pharmaceuticals Ltd a pharmaceutical contract development and manufacturing organization offering a comprehensive range of pharmaceutical products and services in India and overseas. Its services include formulation research and development (R&D), preparation and filing of regulatory dossiers in the Indian and Outside markets, and other testing services. It is also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). It operates in five segments: Contract Development and Manufacturing Operations, Active Pharmaceutical Ingredient (API), Domestic Branded formulations, International Branded Formulations, and Trade generics. Key revenue is generated from Contract Development and Manufacturing Operations.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 8.77 | |||||
Equity-to-Asset | 0.61 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | 0.31 | |||||
Interest Coverage | 4.28 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 5.13 | |||||
Beneish M-Score | -3.41 | |||||
WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.9 | |||||
3-Year EBITDA Growth Rate | 27.6 | |||||
3-Year EPS without NRI Growth Rate | 35.2 | |||||
3-Year Book Growth Rate | 66.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 30.49 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 14.54 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 28.62 | |||||
9-Day RSI | 43.27 | |||||
14-Day RSI | 50.99 | |||||
3-1 Month Momentum % | 13.86 | |||||
6-1 Month Momentum % | 41.77 | |||||
12-1 Month Momentum % | 20.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.25 | |||||
Quick Ratio | 2.56 | |||||
Cash Ratio | 1.54 | |||||
Days Inventory | 100.92 | |||||
Days Sales Outstanding | 64.56 | |||||
Days Payable | 89.79 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.15 | |||||
Forward Dividend Yield % | 0.15 | |||||
5-Year Yield-on-Cost % | 0.15 | |||||
Shareholder Yield % | 1.76 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 42.34 | |||||
Operating Margin % | 8.43 | |||||
Net Margin % | 5.85 | |||||
EBITDA Margin % | 14.28 | |||||
FCF Margin % | 21.81 | |||||
OCF Margin % | 27.1 | |||||
ROE % | 8.05 | |||||
ROA % | 5.2 | |||||
ROIC % | 8.48 | |||||
3-Year ROIIC % | 21.88 | |||||
ROC (Joel Greenblatt) % | 19.25 | |||||
ROCE % | 11.8 | |||||
Years of Profitability over Past 10-Year | 4 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 39.56 | |||||
Forward PE Ratio | 27.3 | |||||
PE Ratio without NRI | 37.57 | |||||
Price-to-Owner-Earnings | 11.55 | |||||
PS Ratio | 2.31 | |||||
PB Ratio | 3.05 | |||||
Price-to-Tangible-Book | 3.04 | |||||
Price-to-Free-Cash-Flow | 10.61 | |||||
Price-to-Operating-Cash-Flow | 8.55 | |||||
EV-to-EBIT | 18.39 | |||||
EV-to-EBITDA | 13.82 | |||||
EV-to-Revenue | 1.98 | |||||
EV-to-FCF | 9.47 | |||||
Price-to-Graham-Number | 2.24 | |||||
| Price-to-Net-Current-Asset-Value | 7.04 | |||||
Earnings Yield (Greenblatt) % | 5.43 | |||||
FCF Yield % | 9.44 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Akums Drugs and Pharmaceuticals Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 43,590.17 | ||
| EPS (TTM) (₹) | 16.67 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 34.22 | ||
| 14-Day RSI | 50.99 | ||
| 14-Day ATR (₹) | 20.837758 | ||
| 20-Day SMA (₹) | 673.255 | ||
| 12-1 Month Momentum % | 20.01 | ||
| 52-Week Range (₹) | 409.3 - 714.7 | ||
| Shares Outstanding (Mil) | 153.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Akums Drugs and Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Akums Drugs and Pharmaceuticals Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 1.000000 Cash Dividend | 2026-07-03 | 637.45 (+0.70%) | ||
| INR 2.000000 Cash Dividend | 2026-07-03 | 637.45 (+0.70%) |
Show
Entries
Akums Drugs and Pharmaceuticals Ltd Frequently Asked Questions
What is Akums Drugs and Pharmaceuticals Ltd(NSE:AKUMS)'s stock price today?
The current price of NSE:AKUMS is ₹658.35. The 52 week high of NSE:AKUMS is ₹714.70 and 52 week low is ₹409.30.
When is next earnings date of Akums Drugs and Pharmaceuticals Ltd(NSE:AKUMS)?
The next earnings date of Akums Drugs and Pharmaceuticals Ltd(NSE:AKUMS) is .
Does Akums Drugs and Pharmaceuticals Ltd(NSE:AKUMS) pay dividends? If so, how much?
The Dividend Yield %  of Akums Drugs and Pharmaceuticals Ltd(NSE:AKUMS) is 0.15% (As of Today), Highest Dividend Payout Ratio of Akums Drugs and Pharmaceuticals Ltd(NSE:AKUMS) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Akums Drugs and Pharmaceuticals Ltd(NSE:AKUMS) is 0.15%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Akums Drugs and Pharmaceuticals Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers